Rebecca Taub, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 440 shares at $545.79 ($242K) on 2026-01-09, disclosed to the SEC on 2026-01-13.
Seasonal sale ($242k) by Director — this insider has traded MDGL in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $545.79 | 40 | $22K | 9.0% |
| 2 | $551.24 | 200 | $110K | 45.5% |
| 3 | $551.24 | 200 | $110K | 45.5% |
| Total | $550.75 avg | 440 | $242K | 100% |
| Filing → |
| MDGL | SELL | 2026-01-20 | $1.1M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $18.9M | — | Filing → |
| MDGL | SELL | 2025-12-12 | $20.5M | — | Filing → |